Your browser doesn't support javascript.
loading
The transcription factor NFAT5 limits infection-induced type I interferon responses.
Huerga Encabo, Hector; Traveset, Laia; Argilaguet, Jordi; Angulo, Ana; Nistal-Villán, Estanislao; Jaiswal, Rahul; Escalante, Carlos R; Gekas, Christos; Meyerhans, Andreas; Aramburu, Jose; López-Rodríguez, Cristina.
Afiliação
  • Huerga Encabo H; Immunology Unit, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
  • Traveset L; Immunology Unit, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
  • Argilaguet J; Infection Biology Laboratory, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
  • Angulo A; Immunology Unit, Department of Biomedical Sciences, Medical School, University of Barcelona, Barcelona, Spain.
  • Nistal-Villán E; Microbiology Section, Departamento de Ciencias, Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad CEU San Pablo, CEU Universities, Madrid, Spain.
  • Jaiswal R; Department of Physiology and Biophysics, Virginia Commonwealth University School of Medicine, Richmond, VA.
  • Escalante CR; Department of Physiology and Biophysics, Virginia Commonwealth University School of Medicine, Richmond, VA.
  • Gekas C; Program in Cancer Research, Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.
  • Meyerhans A; Infection Biology Laboratory, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
  • Aramburu J; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain.
  • López-Rodríguez C; Immunology Unit, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
J Exp Med ; 217(3)2020 03 02.
Article em En | MEDLINE | ID: mdl-31816635
ABSTRACT
Type I interferon (IFN-I) provides effective antiviral immunity but can exacerbate harmful inflammatory reactions and cause hematopoietic stem cell (HSC) exhaustion; therefore, IFN-I expression must be tightly controlled. While signaling mechanisms that limit IFN-I induction and function have been extensively studied, less is known about transcriptional repressors acting directly on IFN-I regulatory regions. We show that NFAT5, an activator of macrophage pro-inflammatory responses, represses Toll-like receptor 3 and virus-induced expression of IFN-I in macrophages and dendritic cells. Mice lacking NFAT5 exhibit increased IFN-I production and better control of viral burden upon LCMV infection but show exacerbated HSC activation under systemic poly(IC)-induced inflammation. We identify IFNß as a primary target repressed by NFAT5, which opposes the master IFN-I inducer IRF3 by binding to an evolutionarily conserved sequence in the IFNB1 enhanceosome that overlaps a key IRF site. These findings illustrate how IFN-I responses are balanced by simultaneously opposing transcription factors.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Interferon Tipo I Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: J Exp Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Interferon Tipo I Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: J Exp Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha